The Perl Toolchain Summit needs more sponsors. If your company depends on Perl, please support this very important event.
*RECORD*
*FIELD* NO
100500
*FIELD* TI
*100500 title
;;title1;;
title2;;
title3

*FIELD* MN
Mini MIM text

*FIELD* CN
Mini MIM - cn
*FIELD* CD
Mini MIM - cd
*FIELD* ED
Mini MIM - ed

*FIELD* TX
DESCRIPTION1

*FIELD* TX
DESCRIPTION2
 
*FIELD* AV
.0001
ALCOHOL INTOLERANCE, ACUTE
ACETALDEHYDE DEHYDROGENASE 2, ALLELE 2, INCLUDED; ALDH2*2, INCLUDED XXX!
ACETALDEHYDE DEHYDROGENASE 2, ALLELE 2, INCLUDED; ALDH2*2, INCLUDED XXX!
ACETALDEHYDE DEHYDROGENASE 2, ALLELE 2, INCLUDED; ALDH2*2, INCLUDED XXX! 
ALDH2, GLU487LYS

AV1-text

.0002
MYASTHENIC SYNDROME, SLOW-CHANNEL CONGENITAL
ACETALDEHYDE DEHYDROGENASE 2, ALLELE 2, INCLUDED; ALDH2*2, INCLUDED XXX!
CHRNA1, VAL156MET

AV2-text

.0003
MYASTHENIC SYNDROME, SLOW-CHANNEL CONGENITAL
CHRNE, ARG147LEU

AV2-text a
AV2-text b

.0004
MYASTHENIC SYNDROME, SLOW-CHANNEL CONGENITAL
CHRNE, 1-BP DEL, 911T

Sieb et al. (2000) found that a brother and sister with congenital
myasthenic syndrome (601462) were compound heterozygotes for a deletion
of 911T and a splicing mutation (IVS4+1G-A; 100725.0007).

.0005
MYASTHENIC SYNDROME, SLOW-CHANNEL CONGENITAL
CHRNE, IVS4DS, G-A, +1

See 100725.0006 and Sieb et al. (2000).

.0006
MYASTHENIC SYNDROME, SLOW-CHANNEL CONGENITAL
CHRNE, 1-BP DEL, 1030C

AV6-text




*FIELD* SA
sa

*FIELD* RF
1. Author11, A. A.; Author12, A. A.: Title 1. Am. J. Med. Genet1. 11: 11-111, 1981.

2. Author21, A. A.; Author22, A. A.: Title 2. Am. J. Med. Genet2. 12: 22-222, 1982.

3. Author31, A. A.; Author32, A. A.: Title 3. Am. J. Med. Genet3. 13: 33-333, 1983.

4. other reference undef format

*FIELD* CS

clinical symptoms

*FIELD* CN
cn1

*FIELD* CD
cd1

*FIELD* ED
ed1

*FIELD* CN
cn2
cn3

*FIELD* ED
ed2
ed3


*FIELD* CD
cd2
cd3





*RECORD*
*FIELD* NO
100501
*FIELD* TI
#100501 second entry
;;title1;;
title2;;
title3

*FIELD* MN
Mini MIM text

*FIELD* CN
Mini MIM - cn
*FIELD* CD
Mini MIM - cd
*FIELD* ED
Mini MIM - ed

*FIELD* TX
DESCRIPTION1

*FIELD* TX
DESCRIPTION2
 
*FIELD* AV
.0001
ALCOHOL INTOLERANCE, ACUTE
ACETALDEHYDE DEHYDROGENASE 2, ALLELE 2, INCLUDED; ALDH2*2, INCLUDED XXX!
ACETALDEHYDE DEHYDROGENASE 2, ALLELE 2, INCLUDED; ALDH2*2, INCLUDED XXX!
ACETALDEHYDE DEHYDROGENASE 2, ALLELE 2, INCLUDED; ALDH2*2, INCLUDED XXX! 
ALDH2, GLU487LYS

AV1-text

.0002
MYASTHENIC SYNDROME, SLOW-CHANNEL CONGENITAL
ACETALDEHYDE DEHYDROGENASE 2, ALLELE 2, INCLUDED; ALDH2*2, INCLUDED XXX!
CHRNA1, VAL156MET

AV2-text

.0003
MYASTHENIC SYNDROME, SLOW-CHANNEL CONGENITAL
CHRNE, ARG147LEU

AV2-text a
AV2-text b

.0004
MYASTHENIC SYNDROME, SLOW-CHANNEL CONGENITAL
CHRNE, 1-BP DEL, 911T

Sieb et al. (2000) found that a brother and sister with congenital
myasthenic syndrome (601462) were compound heterozygotes for a deletion
of 911T and a splicing mutation (IVS4+1G-A; 100725.0007).

.0005
MYASTHENIC SYNDROME, SLOW-CHANNEL CONGENITAL
CHRNE, IVS4DS, G-A, +1

See 100725.0006 and Sieb et al. (2000).

.0006
MYASTHENIC SYNDROME, SLOW-CHANNEL CONGENITAL
CHRNE, 1-BP DEL, 1030C

AV6-text




*FIELD* SA
sa

*FIELD* RF
1. Author11, A. A.; Author12, A. A.: Title 1. Am. J. Med. Genet1. 11: 11-111, 1981.

2. Author21, A. A.; Author22, A. A.: Title 2. Am. J. Med. Genet2. 12: 22-222, 1982.

3. Author31, A. A.; Author32, A. A.: Title 3. Am. J. Med. Genet3. 13: 33-333, 1983.

4. other reference undef format

*FIELD* CS

clinical symptoms

*FIELD* CN
cn1

*FIELD* CD
cd1

*FIELD* ED
ed1

*FIELD* CN
cn2
cn3

*FIELD* ED
ed2
ed3


*FIELD* CD
cd2
cd3